Evidence map›Paper›PMID 36815513›Full record

ArticleMolecular imaging and radionuclide therapy2023

The Role of

Mine Araz, Çiğdem Soydal, Özgür Demir, Mustafa Kürşat Gökcan, Nuriye Özlem Küçük

Open access · diamondAbstract read
In one paragraph

Article in Molecular imaging and radionuclide therapy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Preclinical evaluation ofEuropean journal of nuclear medicine and molecular imaging · 2025
    Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Mine ArazAnkara University Faculty of Medicine, Department of Nuclear Medicine, Ankara, TurkeyORCID 0000-0001-6467-618X
Çiğdem SoydalAnkara University Faculty of Medicine, Department of Nuclear Medicine, Ankara, TurkeyORCID 0000-0002-6199-8551
Özgür DemirAnkara University Faculty of Medicine, Department of Endocrinology and Metabolism, Ankara, TurkeyORCID 0000-0001-6555-3579
Mustafa Kürşat GökcanAnkara University Faculty of Medicine, Department of Otorhinolaryngology and Head and Neck Surgery, Ankara, TurkeyORCID 0000-0002-4160-7349
Nuriye Özlem KüçükAnkara University Faculty of Medicine, Department of Nuclear Medicine, Ankara, TurkeyORCID 0000-0002-0717-8261
Ankara University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: To evaluate the diagnostic performance of Methods: The patients who had undergone Results: A total of 14 patients (9 F and 5 M; median age: 45) were included in the analysis. Three patients had MEN IIA syndrome and 1 patient had MEN IIB syndrome, 10 patients had a diagnosis of sporadic MTC. Median calcitonin levels of the patients were calculated as 757.5 (min-max: 28.5-7911) pg/mL. Nine patients and 5 patients had undergone ultrasound and contrast-enhanced computed tomography (ceCT) of the neck, respectively, before Conclusion:

Indexed as

18F-FDOPAcalcitoninMedullary thyroid cancerPET/CT

Identifiers

PMID36815513
PMCPMC9950688
OpenAlexW4321602510

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.